FDA Again Delays Expanded Use Of Blood Thinner Xarelto
The U.S. Food and Drug Administration has delayed for the second time a decision to expand use of Johnson & Johnson and Bayer AG's blood thinner Xarelto to allow for the...To view the full article, register now.
Already a subscriber? Click here to view full article